Sign inJoin waitlistJoin the waitlist

MT

Michael Tanaka

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit…
Journal of Clinical Oncology · 2008 · 827 citations
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment
Journal of Clinical Oncology · 2001 · 504 citations
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Cancer Chemotherapy and Pharmacology · 2009 · 234 citations

David Gandara
13 papers
DL
Derick Lau
9 papers
Primo Lara
9 papers
AD
Angela Davies
4 papers
Frederick Meyers
3 papers
Heinz-Josef Lenz
3 papers
JM
John Macdonald
3 papers
Scott Christensen
3 papers
SS
Sidney Scudder
3 papers
CR
Carol Richman
2 papers
CH
Cheryl Ho
2 papers
Edward Kim
2 papers